Trending Now
Bam Bam Resources (NPEZF) could be well positioned to take advantage...
According to an article published by Bloomberg (1), the world may face a massive shortfall of what’s arguably the most critical metal...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Ligand OmniAb® Partner Immunovant Inc. (NASDAQ:IMVT) Says the Phase 2a Trial...
A Phase 2a study of OmniAb-derived IMVT-1401 being carried out by Ligand OmniAb® Partner Immunovant Inc. (NASDAQ:IMVT) has delivered positive topline results. The study,...
MAKE IT MODERN
LATEST REVIEWS
BioCardia (NASDAQ:BCDA) Receives Positive Recommendation To Continue Piboatl CardiAMP™ Heart Failure...
BioCardia (NASDAQ:BCDA) has announced the completion of its pre-specified data review for its third phase pivotal CardiAMP™ Heart Failure Trial. The independent...
MAKE IT MODERN
PERFORMANCE TRAINING
Nektar Therapeutics (NASDAQ:NKTR) Reports Q3 2020 Financial Results And Bempegaldesleukin Development Updates
Nektar Therapeutics (NASDAQ:NKTR) has announced its Q3 2020 financial results for the period ended September 30, 2020. At the end of the quarter, the...
BioRestorative Therapies (NASDAQ: BRTX) Advances in Regenerative Medicine with ThermoStem® Licensing Talks
BioRestorative Therapies, Inc. (NASDAQ: BRTX) saw a significant rise in its stock performance today, closing the trading session at $1.9500 with a...
Lipocine Inc (NASDAQ: LPCN ) Issues Shareholders With an Update on LPCN 1144
Lipocine Inc (NASDAQ: LPCN) recently disclosed the position of its remodeled Drug LPCN 1144. In addition, the company disclosed details of its...
NRx Pharmaceuticals (NASDAQ: NRXP) Announce Publication of Aviptadil Study Results In COVID-19 Related Respiratory...
NRx Pharmaceuticals (NASDAQ: NRXP) has published peer-reviewed data from the prospective, open-label, controlled aviptadil study for respiratory failure treatment in patients with Critical coronavirus...
Aytu BioScience Inc. (NASDAQ:AYTU) Announces The Improvement Of Nastesto To Preferred Brands On Express...
Aytu BioScience Inc. (NASDAQ:AYTU) announced that Express Scripts Inc., which is among leading pharmacy benefit managers in the US, will make testosterone nasal gel,...
MAKE IT MODERN
